Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1305, pseudogene (RNU6-1305P) is a processed pseudogene of the U6 small nuclear RNA family in humans. Pseudogenes such as RNU6-1305P are typically non-functional remnants of genes that have lost their protein-coding ability or are otherwise nonfunctional due to mutations in their sequence. While some pseudogenes can have regulatory functions via RNA-based mechanisms (such as competing endogenous RNAs or modulation of parental gene expression), there is no evidence indicating any functional, regulatory, or disease-relevant activity for RNU6-1305P itself. There are no known drugs, clinical biomarkers, or involvement in therapeutic interventions associated with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1305, pseudogene (RNU6-1305P).